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The Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV) Se8 gene was recently shown to encode
the viral envelope fusion (F) protein. A 60-kDa C-terminal subunit (F1) of the 76-kDa primary translation
product of this gene was found to be the major envelope protein of SeMNPV budded virus (BV) (W. F. J. IJkel,
M. Westenberg, R. W. Goldbach, G. W. Blissard, J. M. Vlak, and D. Zuidema, Virology 275:30–41, 2000). A
specific inhibitor was used to show that furin is involved in cleavage of the precursor envelope fusion (F0)
protein. BV produced in the presence of the inhibitor possesses the uncleaved F0 protein, while an F protein
with a mutation in the furin cleavage site was translocated to the plasma membrane but lost its fusogenic
activity. These results indicate that cleavage of F0 is required to activate the SeMNPV F protein and is
necessary for BV infectivity. Specific antibodies against F1 and against the putative N terminus (F2) of the
primary translation product were used to show that the F protein is BV specific and that BVs contain both the
60- (F1) and 21-kDa (F2) cleavage products. In nonreducing sodium dodecyl sulfate-polyacrylamide gel
electrophoresis both subunits migrate as a single 80-kDa protein, indicating that the subunits remain asso-
ciated by a disulfide linkage. In addition, the presence of the F protein predominately as a monomer suggests
that disulfide links are not involved in oligomerization. Thus, the envelope fusion protein from group II
nucleopolyhedroviruses of baculoviruses has properties similar to those of proteins from a number of verte-
brate viruses.
The Baculoviridae are a family of large, enveloped double-
stranded DNA viruses exclusively pathogenic to arthropods,
predominantly insects in the order Lepidoptera (1). Baculovi-
ruses of the genus Nucleopolyhedrovirus (NPV) produce two
distinct virion phenotypes: the occlusion-derived virus (ODV)
and the budded virus (BV) phenotypes (53). ODVs are re-
leased from occlusion bodies due to the alkaline environment
of the insect gut and are able to infect the midgut epithelial
cells by direct membrane fusion (12, 13, 19). BVs infect insect
cells via receptor-mediated endocytosis and are responsible for
the systemic spread of the virus in the insect (17, 54). Upon
acidification of the endosome, the viral and endosomal mem-
branes fuse, thereby allowing entry of the nucleocapsid into the
cytoplasm (4, 17). For group I NPVs, e.g., Autographa califor-
nica AcMNPV, Bombyx mori BmNPV, and Orgyia pseudot-
sugata OpMNPV, this fusion is mediated by envelope fusion
protein GP64 (4, 24, 39). This protein is also required for
efficient budding of newly synthesized nucleocapsids at the
plasma membrane (30, 33). Baculoviruses belonging to group
II NPVs, e.g., SeMNPV (21), Lymantria dispar LdMNPV (26),
and Helicoverpa armigera HaSNPV (7), conspicuously lack a
GP64-like protein.
Recently, a novel type of envelope fusion (F) protein was
identified in BVs of group II NPVs, notably in SeMNPV (22)
and LdMNPV (37). For SeMNPV this F protein is encoded by
ORF8 (Se8) (21). A C-terminal 60-kDa subunit of the 76-kDa
primary translation product was found to be the major enve-
lope protein of SeMNPV BV. Several protein bands with mo-
lecular sizes in the 15- to 17-kDa range were found (22), and
one of these could represent the N-terminal subunit of the F
protein. The involvement of furin in the cleavage was hypoth-
esized on the basis of the presence of furin-like proprotein
convertase site RSKR immediately upstream of the N terminus
of the 60-kDa cleavage product (22).
Cleavage of viral fusion proteins seems to be a general
mechanism to activate these proteins and to produce infectious
viruses. The cleavage takes place in front of a hydrophobic
sequence, the “fusion peptide.” Exposure to low pH or recep-
tor binding triggers a conformational change whereby the fu-
sion peptide is believed to translocate to the top of the mole-
cule and to insert into the target membrane (25). A number of
fusion proteins of vertebrate viruses are cleaved by furin.
These include human cytomegalovirus glycoprotein B (50),
human parainfluenza virus type 3 F (36), Ebola virus glycop-
rotein GP (52), and avian influenza virus hemagglutinin (HA)
(47). The furin-mediated cleavage yields in all these cases two
subunits that are disulfide linked. Furin is localized in the
trans-Golgi network (51) and cleaves after the consensus cleav-
age site R-X-R/K-R (20, 32). The arginine immediately up-
stream of the cleavage site is the most essential amino acid
(32). For Ebola virus envelope protein GP it has been shown
that changing this arginine into a lysine results in an uncleaved
precursor protein (52). Cleavage of some fusion proteins can
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be inhibited by peptidyl-chloroalkylketones containing the R-
X-K/R-R motif, which specifically bind to the catalytic site of
furin (10, 15, 40, 47).
In this paper evidence is provided by using a furin inhibitor
and mutational analysis of the furin-like proprotein convertase
site that cleavage of the SeMNPV BV F protein is mediated by
furin and that this cleavage is required to activate the SeMNPV
F protein to render infectious BVs. Furthermore, whether both
subunits of the primary translation product are present in the
SeMNPV BV and whether these remain associated to each
other are investigated.
MATERIALS AND METHODS
Cells, insects, and viruses. Spodoptera frugiperda cell line IPLB-SF-21 (48) and
Spodoptera exigua cell line Se301 (16) were cultured at 27°C in plastic tissue
culture flasks (Nunc) in Grace’s insect medium, pH 5.9 to 6.1 (Gibco-BRL),
supplemented with 10% fetal bovine serum (FBS). A culture of S. exigua insects
was maintained as described by Smits and Vlak (46). The SeMNPV isolate (11)
was originally obtained from B. A. Federici (Department of Entomology, Uni-
versity of California) and was called SeMNPV-US1 (31). The AcMNPV-E2
strain (45) was originally obtained from M. D. Summers (Texas A&M University,
College Station, Tex.).
Plasmid constructions. The regions coding for amino acids 1 (M) to 149 (R)
(F2) and amino acids 150 (G) to 579 (G) (F1580-665) of ORF8 in the SeMNPV
genome were amplified by high-fidelity Expand long-template PCR (Boehringer
Mannheim) from plasmid pSeBglII-H (21). Primers used to amplify F1580-665
were 5-TTTGGATCCCGGCCTTTTTAATTTTATGG-3 (underlined nucleo-
tides generated a BamHI site) and 5-AATAAGCTTAACCGATGCTGGAAA
ACCACGAAGAC-3 (underlined and boldface nucleotides generated a HindIII
site and a translation stop codon, respectively). Primers used for amplifying F2
were 5-TTGGGATCCTATGCTGCGTTTTAAAGTGATTGTG-3 (under-
lined nucleotides generated a BamHI site) and 5-ATTAAGCTTAGCGTTTA
GAGCGTCTTTTCGTCG-3 (underlined and boldface nucleotides generated a
HindIII site and a translation stop codon, respectively). The PCR products were
cloned into the BamHI and HindIII cloning sites of expression vector pET28a
(Novagen) to generate pET28-SeF1580-665 and pET28-SeF2.
PCR-based site-directed mutation of the arginine (R149) immediately up-
stream of the convertase cleavage site into a lysine (K149) was performed
according to the method of Sharrocks and Shaw (43). The 5 primer 5-TTAT
GGATCCATGCTGCGTTTTAAAGTGATTGTG-3 and the 3 mutagenic
primer 5-CCCATAAAATTAAAAAGGCCCTTTTTAGAGCGTCTTTTCGT
CG-3 (underlined nucleotides generated the mutation) were used in conjunc-
tion with plasmid p166AcV5-Se8 (22) as a template to introduce the R149-to-
K149 mutation using high-fidelity Expand long-template PCR (Boehringer
Mannheim). The PCR product was agarose gel purified, and the single strand
containing the mutation at the 3 end served as a 5mutagenic primer in a second
PCR together with 3 primer 5-GAGAGGCACGGGCCACGAAAGG-3. The
second PCR product was cloned into pGEM-T (Promega) to generate pGEM-
Se8(K149). Plasmids p166AcV5-Se8(K149) and p166AcV5-Se8(K149)GFP were
obtained by exchanging the BamHI/StuI fragment of pGEM-Se8(K149) with
those of p166AcV5-Se8 and p166AcV5-Se8GFP (22), respectively.
Production of polyclonal antibodies. Proteins F1580-665 and F2 were ex-
pressed in Escherichia coli Bl21 cells containing vector pET28-SeF1580-676 or
pET2-SeF2 and were purified as described previously (23). The proteins were
concentrated using a Centriprep 10-kDa filter device (Amicon) and dialyzed
against phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8.1 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Protein concentrations were determined
with the Bio-Rad protein assay.
Two chickens were injected intramuscularly with either 200 g of purified
F1580-665 or F2 protein using a water-in-oil adjuvant. The chickens were
boosted after 4 weeks with 150 g of purified protein. Two weeks after the
booster, eggs were collected every day for 2 weeks. The egg yolk was diluted
threefold (wt/wt) in PBS containing 5.25% polyethylene glycol 6000 (PEG-6000)
and 0.05% NaN3. The mixture was centrifuged for 15 min at 2,250  g. The
supernatant was filtered through glass wool, and PEG-6000 was added until 12%
(wt/vol) was reached. After centrifugation for 15 min at 2,250  g, the pellet was
dissolved in water and centrifuged as before to remove debris. PEG-6000 was
added to the solution until 12% (wt/vol) was reached, and centrifugation for 20
min at 2,250  g was performed. The pellet containing polyclonal antibodies
against fusion protein subunit F1 (-F1) or F2 (-F2) was dissolved in 2.5 ml of
0.9% NaCl per egg and stored at 20°C.
Purification of SeMNPV BV and ODV. Hemolymph-derived BVs were purified
from SeMNPV-infected S. exigua fourth-instar larvae as described previously
(22) with some modifications. Briefly, 3 days postinfection (p.i.) hemolymph was
collected and clarified at 2,000 g for 10 min at 4°C. The supernatant was passed
through a 0.45-m-pore-size filter. BVs in the filtrate were pelleted through a
25% (wt/wt) sucrose cushion made up in 0.1 TE (10 mM Tris-HCl [pH 7.5], 1.0
mM EDTA) by centrifugation at 100,000  g for 90 min at 4°C and resuspended
in 0.1 TE. BVs from cell culture supernatants were purified in a similar fashion.
Se301 cells were infected with 0.1 50% tissue culture infective dose (TCID50) of
SeMNPV/cell. Seventy-two hours p.i. cell culture supernatants were clarified at
2,000  g for 10 min at 4°C and passed through a 0.45-m-pore-size filter. BVs
in the filtrate were pelleted and resuspended as described above. ODVs were
purified from polyhedra derived from SeMNPV-infected S. exigua fourth-instar
larvae as described previously (22). The purity and integrity of BVs and ODVs
were checked by electron microscopy.
Western blot analysis. For electrophoresis under reducing conditions purified
SeMNPV ODVs and BVs were disrupted in Laemmli buffer (125 mM Tris-HCl,
2% sodium dodecyl sulfate [SDS], 5% 2-mercaptoethanol, 10% glycerol, 0.001%
bromophenol blue, pH 6.8). For electrophoresis under nonreducing conditions
virions were disrupted in 125 mM Tris-HCl–8% SDS–37.5 mM iodoacetamide–
10% glycerol–0.001% bromophenol blue, pH 6.8. Samples were denatured for 10
min at 95°C. Proteins were electrophoresed in SDS-polyacrylamide gels and
transferred onto Immobilon-P membranes (Millipore) by semidry electrophore-
sis transfer (2). Membranes were blocked overnight at 4°C in PBS containing 2%
milk powder, followed by incubation for 1 h at room temperature (RT) with
antiserum at a dilution of 1:1,000 in PBS containing 0.2% milk power. After
being washed three times for 15 min in PBS-T (PBS containing 0.1% Tween 20),
the membranes were incubated for 1 h at RT with horseradish peroxidase
conjugated with rabbit anti-chicken immunoglubulin (Sigma) diluted 1:50,000 in
PBS containing 0.2% milk powder. After three washes for 15 min in PBS-T, the
signal was detected by ECL technology as described by the manufacturer (Am-
ersham).
Furin inhibition assay. Se301 cells (2.0  105) were infected with 10 TCID50s
of SeMNPV or AcMNPV/cell. At 2 h p.i. cells were washed twice with medium
and incubated with medium containing a 50 M concentration of furin cleavage
inhibitor decanoylated arginyl-valyl-lysyl-arginyl chloromethylketone (dec-RVKR-
cmk) (Bachem). The AcMNPV-infected cells were incubated without dec-
RVKR-cmk. Cell culture supernatants were collected at 48 h p.i, and infectious
BV was quantified by a TCID50 assay (35) on Se301 cells. The SeMNPV-infected
cells were washed three times with medium without FBS and assayed for the
presence of active fusion proteins in the plasma membrane by a syncytium
formation assay as described below.
Syncytium formation assay. Syncytium formation assays were performed by
transfection of 5.0  105 Sf21 cells with 5 g of DNA of p166AcV5-Se8 or
p166AcV5-Se8(K149) using CellFECTIN (Gibco-BRL). Empty vector p166BRNX-
AcV5 (22) was used as a negative control for the syncytium formation assay.
Forty-eight hours after transfection, cells were washed three times with medium
without FBS and treated for 2 min in acidic medium without FBS, pH 5.0. The
acidic medium was replaced with medium with FBS, pH 6.1. Syncytium forma-
tion was recorded by light microscopy 4 h after treatment with the acidic me-
dium. Syncytium formation was positive when at least four nuclei were present in
each syncytial mass.
Fluorescence microscopy. To investigate the cellular location of the mutant
SeMNPV F protein, 1.0  105 Sf21 cells were grown on glass coverslips and
transfected with 5 g of DNA of p166AcV5-Se8GFP or p166AcV5-Se8(K149)
GFP. As a control for green fluorescent protein (GFP), expression plasmid
p166AcV5-GFP (22) was used. At 48 h posttransfection the localization of GFP
in the cells was examined with a Zeiss LSM510 (confocal) laser scanning micro-
scope for fluorescence using an excitation wavelength of 488 nm and an emission
bandpass filter of 505 to 530 nm.
Computer-assisted analysis. The SeMNPV F protein was analyzed for several
protein motifs using different bioinformation programs. N-terminal signal se-
quences were found with program PSORT II (National Institute for Basic Biol-
ogy [http://www.nibb.ac.jp]). Possible coiled-coil regions in the protein were
predicted using the program PairCoil (version 1.0; MIT Laboratory for Com-
puter Science [http://www.lcs.mit.edu]). Comparisons between the SeMNPV F
protein and other viral fusion proteins were done with program FASTA (version
3; EMBL-European Bioinformatics Institute [http://www.ebi.ac.uk]). Sequence
alignments were performed with program ClustalW (EMBL-European Bioinfor-
matics Institute [http://www.ebi.ac.uk]).
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RESULTS
Inhibition of furin-mediated cleavage. ORF8 (Se8) of SeM-
NPV was recently shown to encode the viral fusion (F) protein.
A 60-kDa C-terminal subunit (F1) of the primary Se8 transla-
tion product was present in the envelopes of BVs, which were
purified from hemolymph of infected S. exigua larvae (22).
Amino acid sequence RSKR immediately upstream of the N
terminus of 60-kDa subunit F1 is consistent with a consensus
cleavage site of furin-like endoproteases (22), and this suggests
that F1 is a cleavage product of a precursor, F0, of the envelope
fusion protein. To demonstrate that F0 is subjected to proteo-
lytic cleavage by furin and that cleavage is important for infec-
tivity, furin inhibitor dec-RVKR-cmk was used. This inhibitor
penetrates into cells and specifically binds to the catalytic site
of furin (10, 15, 40, 47) and thus may inhibit the production of
infectious SeMNPV BV.
Supernatants of SeMNPV-infected Se301 cells (48 h p.i.),
grown in the presence or absence of dec-RVKR-cmk (50 M),
were assayed for the amount of infectious progeny BV by
determining TCID50s. In the presence of the furin inhibitor the
virus titer was reduced dramatically to 2% of the titer for the
control (absence of the inhibitor) (Fig. 1, lanes 1 and 2). This
drop could be caused by either distortion in the BV assembly
pathway, giving no new progeny BVs, or by progeny BVs that
are not infectious anymore due to the presence of uncleaved
fusion proteins (F0) in their envelopes. In a similar experiment
with AcMNPV the furin inhibitor had no effect on the virus
titer (Fig. 1, lanes 3 and 4), indicating that the furin inhibitor
did not affect the formation of BV per se.
To exclude the possibility that the drop in SeMNPV virus
titer was due to an impairment of the SeMNPV BV assembly
pathway, progeny BVs were isolated from cell cultures incu-
bated in the presence or absence of dec-RVKR-cmk. Western
analysis with polyclonal antibodies against F1 (-F1) revealed
the presence of a 60-kDa protein (F1) in both BV preparations
(Fig. 2, lanes 1 and 2). BV obtained from cell cultures incu-
bated in the presence of the furin inhibitor possessed an ad-
ditional 80-kDa protein (F0) (Fig. 2, lane 2). These experi-
ments showed that blocking the furin-mediated cleavage of F0
did not impair the assembly of BVs.
SeMNPV F protein with mutated cleavage site is unable to
trigger fusion. Previously, it was demonstrated that acidifica-
tion of the medium of SeMNPV-infected Se301 cells resulted
in syncytium formation (22). To determine whether inhibition
of furin-mediated cleavage would also inhibit activation of
membrane fusion activity by the F protein, Se301 cells were
infected with SeMNPV in the presence of dec-RVKR-cmk.
After a pH drop to 5.0, cells were examined for their ability to
form syncytia (48 h p.i.). Control cells infected in the absence
of the furin inhibitor showed cell-to-cell fusion (Fig. 3A),
whereas in the presence of the furin inhibitor cell-to-cell fusion
was not observed (Fig. 3B). This suggests that uncleaved pre-
cursor F0 is unable to trigger cell-to cell fusion.
To obtain direct evidence that the F0 protein of SeMNPV
has no fusogenic activity, consensus furin cleavage site RSKR
of the F protein was mutated by changing the arginine (R) at
amino acid residue 149 (upstream of the cleavage site) into a
lysine (K). Whether the mutant FK149 protein could be trans-
ported to the plasma membrane was examined first. Sf21 cells
instead of Se301 cells (Se301 cells are difficult to transfect, and
cell-to-cell fusion is difficult to monitor due to the multimor-
phic cell phenotypes found in this cell line) were transfected
with plasmids containing either the wild-type F (p166AcV5-
Se8GFP) or the mutant FK149 (p166AcV5-Se8(K149)GFP)
open reading frame, which was fused C-terminally to GFP
under the control of an optimized OpMNPV gp64 promoter to
facilitate expression in insect cells (3). Both wild-type F and
mutant FK149 proteins were predominantly localized in the
plasma membrane 48 h after the transfection (Fig. 4A and B).
The GFP protein alone (p166AcV5-GFP) showed a homoge-
neous fluorescence signal in the cytoplasm and nuclei of Sf21
FIG. 1. Effect of furin inhibitor dec-RVKR-cmk on SeMNPV and
AcMNPV BV infectivity. Se301 cells were infected with SeMNPV
(lanes 1 and 2) or AcMNPV (lanes 3 and 4) in the presence (lanes 2
and 4) or absence (lanes 1 and 3) of furin inhibitor dec-RVKR-cmk. At
48 h p.i. the titer of progeny infectious BV in the cell culture super-
natants was determined by TCID50 assays. The data presented are
means and standard deviations of three independent experiments.
FIG. 2. Western blot analysis of proteins obtained from SeMNPV
BV, produced in the absence (; lane 1) or presence (; lane 2) of
furin inhibitor dec-RVKR-cmk. BVs were incubated for 10 min at
95°C in Laemmli buffer and subjected to SDS-PAGE (12% polyacryl-
amide). Proteins were transferred onto an Immobilon-P membrane
(Millipore), incubated with -F1, and detected with a chemilumines-
cent substrate. Size standards in kilodaltons are on the left. F0, pre-
cursor SeMNPV F protein; F1, 60-kDa subunit of SeMNPV F protein.
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cells (Fig. 4C), suggesting that the mutation does not affect the
transport of the F protein to the plasma membrane.
To examine whether the FK149 protein is able to trigger
cell-to-cell fusion upon lowering the pH of the medium, Sf21
cells were transfected with similar constructs without the C-
terminal GFP fusion. Cells transfected with the wild-type F
construct (p166AcV5-Se8) clearly showed pH-dependent cell-
to-cell fusion (Fig. 4D). The FK149 protein [p166AcV5-
Se8(K149)] did not trigger cell-to-cell fusion (Fig. 4E), similar
to what was found for the cells transfected with the empty
vector (p166BRNX-AcV5) (Fig. 4F). So, it is concluded that
the SeMNPV F protein requires cleavage by furin to become
active as a fusion protein.
SeMNPV BV contains both F protein subunits. Cleavage of
the F0 precursor yields, besides the 60-kDa C-terminal cleav-
age product (F1), a product of approximately 15 kDa (the
N-terminal subunit minus the signal peptide; F2). Several pro-
teins in the 15- to 17-kDa range from BVs purified from he-
molymph of SeMNPV-infected S. exigua larvae have been re-
ported (22).
To determine whether SeMNPV BV contains both mature F
subunits (F1 and F2) and whether cleavage of the SeMNPV F0
protein occurs in tissue culture as well as in insects, BVs were
purified from cell culture supernatants of SeMNPV-infected
Se301 cells and from hemolymph obtained from SeMNPV-
infected S. exigua larvae. Western analysis with polyclonal an-
tibodies against F1 (-F1) revealed the presence of a 60-kDa
protein in BVs obtained from hemolymph as well as from cell
culture (Fig. 5, lanes 1 and 2). Polyclonal antibodies specific
against F2 (-F2) detected a 21-kDa protein in both BV prep-
arations (Fig. 5, lanes 4 and 5). Neither antibodies against F1
nor antibodies against F2 reacted with ODV-derived proteins
(Fig. 5, lanes 3 and 6), demonstrating that both F protein
subunits are BV specific.
Processing and oligomerization of the SeMNPV F protein.
The observation that both subunits, F1 and F2, were present in
SeMNPV BV raised the question of whether these subunits
interacted with each other. There is a possibility that these
subunits remain noncovalently associated, as found for the
fusion protein of the Retroviridae (Env) (49), or are covalently
associated by disulfide linkage, as found for fusion proteins in
members of the Orthomyxoviridae (HA), Herpesviridae (gB),
and Paramyxoviridae (F) (28, 29, 42).
To determine the type of interaction between F1 and F2,
SeMNPV BV proteins were treated with iodoacetamide, which
alkylates free sulfhydryl groups and thereby prevents artificial
disulfide exchange during further treatment or electrophoresis
(14). The proteins were denatured in the absence of reducing
FIG. 3. SeMNPV-mediated fusion of Se301 cells. Cells were infected with SeMNPV in the absence (A) or presence (B) of furin inhibitor
dec-RVKR-cmk. Forty-eight hours p.i. cells were incubated for 2 min with medium, pH 5.0. Syncytium formation was scored 4 h after dropping
the pH by phase-contrast microscopy.
FIG. 4. Localization studies with SeMNPV wild-type F and mutant FK149-GFP fusion proteins (A to C) and their ability to mediate cell-to-cell
fusion in Sf21 cells (D to F). For the localization studies, Sf21 cells were transfected with plasmid p166AcV5-Se8GFP (A), p166AcV5-
Se8(K149)GFP (B), or control plasmid p166AcV5-GFP (C). Fluorescence was examined 48 h after transfection by confocal laser scanning
microscopy. For pH-dependent membrane fusion, Sf21 cells were transfected with plasmid p166AcV5-Se8 (D), p166AcV5-Se8(K149) (E), or
control p166BRNX-AcV5 (F). Forty-eight hours after transfection, cells were treated for 2 min with medium, pH 5.0. Four hours after the pH drop
syncytium formation was scored by phase-contrast microscopy.
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agents and electrophoresed in a 12% polyacrylamide gel.
Western analysis with -F1 and -F2 detected in both cases a
single protein with a molecular mass of 80 kDa (F1,2) (Fig. 6A,
lanes 1 and 2). The absence of free F1 and F2 indicates that
these subunits remain covalently linked after cleavage.
To investigate whether F proteins from SeMNPV also form
disulfide-linked oligomers, a nonreducing SDS-polyacrylamide
gel electrophoresis (PAGE) was performed using a 6% poly-
acrylamide gel. Antibodies -F1 and -F2 detected a major
monomeric form of 80 kDa (Fig. 6B, lanes 1 and 2). Antibody
-F2 detected also a possible dimeric form as a minor band of
155 kDa (Fig. 6B, lane 2); higher multimeric forms were not
detected.
DISCUSSION
Posttranslational cleavage of fusion proteins of enveloped
viruses seems to represent a general mechanism used to reg-
ulate viral membrane fusion activity. All members of the Or-
thomyxoviridae, Paramyxoviridae, Togoviridae, Coronaviridae,
Retroviridae, and Herpesviridae express their fusion proteins as
a precursors, which have to be cleaved by host proteases to
render infectious virus (25). The cleavage usually takes place in
front of a hydrophobic sequence, the fusion peptide. Exposure
to low pH or binding to a receptor triggers a conformational
change in which the fusion peptide is believed to translocate
and insert itself into the target membrane (25).
In this report it is demonstrated that SeMNPV, a represen-
tative of a group II NPV within the Baculoviridae, also ex-
presses its fusion protein as precursor F0. This precursor is
posttranslationally cleaved by insect cell furin into two disul-
fide-linked subunits, F1 and F2, to become active in tissue
culture and in insects. The major envelope protein of HaSNPV
BV, the product of Ha133, has also been identified and char-
acterized (7; M. Westenberg and H. Z. Wang, personal com-
munication). This protein turned out to be also a C-terminal
cleavage product of the SeMNPV F protein homolog. In con-
trast to the SeMNPV and HaSNPV F proteins, the LdMNPV
BV F protein was reported not to be cleaved (37), despite the
fact that it possesses a similar furin cleavage site at a position
analogous to those in SeMNPV and HaSNPV. An 83-kDa
fusion protein was detected in LdMNPV BV purified from cell
culture supernatants. Tunicamycin treatment of the cells re-
sulted in an LdMNPV fusion protein with a molecular mass of
72 kDa. The latter value is consistent with a predicted molec-
ular mass of 75 kDa for the product of the whole open reading
frame minus the signal sequence (residues 1 to 16). Therefore
it is most likely that Ld625Y cells are unable to properly cleave
the fusion protein from LdMNPV BV. However the titers of
progeny BVs from Ld625Y cells are even higher (41) than that
of SeMNPV in Se301 cells. So it is very possible that the
activation of the fusion protein of LdMNPV during viral up-
take by Ld625Y cells is similar to the activation of the influenza
virus A/WSN/33 (H1N1) fusion protein in vertebrate cells.
This virus possesses only the uncleaved HA, which is cleaved
during uptake presumably by an endosomal protease (6).
The cleavage of the F0 protein by furin was demonstrated by
the use of a furin inhibitor at a concentration of 50 M, which
seemed to be the most effective concentration (data not
shown). The titers of the progeny BVs produced in the pres-
ence of the inhibitor were about 2% of the control titers (Fig.
1). The 2% residual infectious virus is in agreement with sim-
ilar findings with other viral systems (15, 36, 40) and is probably
FIG. 5. Western blot analysis of reduced proteins of SeMNPV virus
preparations. Cell culture-derived (CC) BVs, hemolymph-derived
(He) BVs, and polyhedra-derived ODVs were incubated for 10 min at
95°C in Laemmli buffer and subjected to SDS-PAGE (12% polyacryl-
amide). Proteins were transferred onto an Immobilon-P membrane
(Millipore), incubated with either -F1 (left) or -F2 (right) antibodies,
and detected with a chemiluminescent substrate. Size standards in
kilodaltons are on the left. F1, 60-kDa subunit of SeMNPV F protein;
F2, 21-kDa subunit of SeMNPV F protein.
FIG. 6. Western blot analysis of nonreduced proteins of SeMNPV
BV. Cell culture-derived BVs were incubated for 10 min at 95°C in the
presence of 37.5 mM iodoacetamide and in the absence of 2-mercap-
toethanol and electrophoresed in a 12% (A) or 6% (B) SDS-polyacryl-
amide gel. Proteins were transferred onto an Immobilon-P membrane
(Millipore), incubated with either -F1 or -F2, and detected with a
chemiluminescent substrate. Size standards (kilodaltons) are indi-
cated. F1,2, 60- and 21-kDa disulfide-linked subunits of SeMNPV F
protein.
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the result of the instability of the furin inhibitor in aqueous
solutions. However, we cannot exclude the possibility that a
small proportion of the F0 protein is cleaved by another un-
known protease. Infected cells were also unable to form syn-
cytia in the presence of the inhibitor (Fig. 3), which is consis-
tent with earlier reports that cell-to-cell fusion after viral
infection could be completely blocked by peptidyl-chloroalky-
lketones (15, 47). BV assembly was not impaired in the pres-
ence of the furin inhibitor (Fig. 2). Nevertheless the amount of
F1 protein relative to the amount of F0 protein is not propor-
tional to the drop in virus titer but is in agreement with similar
findings for influenza virus, where the cleavage inhibition of
HA0 was also not proportional to the drop in hemagglutination
titer (47). For influenza viruses and group I NPVs it has been
shown that at least three HA trimers (5, 8) and approximately
six GP64 trimers (38), respectively, cooperate in the formation
of the fusion pore. So, the presence of even small amounts of
F0 in BVs can interfere with the mature fusion proteins in the
fusion process.
Cleavage products F1 and F2 are covalently associated, sim-
ilar to the fusion proteins of members of the Orthomomyxo-
viridae, Herpesviridae, and Paramyxoviridae (28, 29, 42). The F2
subunit of SeMNPV contains only a single cysteine residue
(C94), which makes this cysteine the only candidate to form
the disulfide bridge with F1. This cysteine residue is conserved
among the F protein homologs of HaSNPV (6) and LdMNPV
(26). In contrast, the F1 subunit contains 15 cysteine residues.
Ten of these are situated upstream of the predicted transmem-
brane region, and 9 of the 10 are conserved among the group
II NPVs (SeMNPV, LdMNPV, HaSNPV). The molecular mass
of the F1 subunit (60 kDa) is in close agreement with the
molecular mass of 59 kDa predicted from the DNA sequence.
The F2 subunit was detected by SDS-PAGE as a 21-kDa pep-
tide (Fig. 5). Upon maturation the F2 subunit might go through
some posttranslational modification processes, including N-
glycosylation and O-glycosylation (22), which may explain the
difference between the theoretical (15 kDa) and actual (21
kDa) sizes of this subunit.
Viral fusion proteins generally form higher-order oligomers
(18). In most cases these oligomers are formed by noncovalent
interactions. However, envelope fusion protein GP64 of group
I NPVs forms a trimer of disulfide-linked monomers (34). The
F protein of SeMNPV was predominantly present as a mono-
mer (Fig. 6B). A minor band approximately twice the size of
the monomer was also detected. Although this band could
represent a dimeric form of the protein, most likely this is due
to incomplete denaturation, since this band was only detected
by -F2. Furthermore, treatment of GP64 of AcMNPV under
the same conditions resulted in the simultaneous occurrence of
trimers together with minor dimers and monomers (data not
shown). Therefore, it is concluded that disulfide links are most
likely not involved in oligomerization of the F protein. The
potential oligomeric structure of the SeMNPV F protein re-
mains to be characterized.
The SeMNPV F protein is very similar in structure to the
paramyxovirus fusion protein. Both consist of a small N-termi-
nal subunit linked by a disulfide bridge to the large C-terminal
membrane-anchored subunit. The SeMNPV F protein has the
highest homology with paramyxovirus human respiratory syn-
cytial virus fusion protein [P03420], with 12% amino acid iden-
tity and 36% similarity. Although the overall homology is not
high (12%), predicted domains such as -helices and -sheets,
as well as the furin cleavage sites, the heptad repeats (HRs),
and the transmembrane regions, are structurally conserved.
Furthermore, the fusion protein of the paramyxoviruses con-
tains a fusion peptide, which is located at the N terminus of
the large membrane-anchored subunit. We predict that the
SeMNPV F protein contains a putative fusion peptide at an
analogous position. Amino acids 150 to 166 GLFNFMGHVD
KYLFGIM contain nine hydrophobic residues (underlined)
with hydrophobicity indices (H.I.) higher than 0.62 according
to the normalized consensus scale of Eisenberg (9). These
hydrophobic residues can be modeled as a hydrophobic face in
an -helix. The average H.I. of the hydrophobic face is 1.1, and
the total amino acid stretch has a H.I. of 0.5, which is consis-
tent with those for other viral fusion proteins (55).
The paramyxovirus fusion proteins contain HRs (HR1 and
HR2) immediately adjacent to the fusion peptide and the
transmembrane domain (27). Previous studies with other viral
fusion proteins suggested that these HRs form trimeric hair-
pin-like structures, with the HR2 regions packing in an anti-
parallel manner against the inner coiled-coil formed by the
HR1 regions. The likely role of the hairpin structure is to
facilitate apposition of the viral and cellular membranes by
bringing the fusion peptide, which inserts into the cellular
membrane, close to the transmembrane segment, which is an-
chored in the viral membrane (44). The SeMNPV F protein
also contains two putative HRs. The first HR is adjacent to the
putative fusion peptide and is formed by amino acid residues
174 to 202 (HR1: LhmLantTnsLnsqVkqLndeLivLadyV, where
the amino acids in uppercase are the nonpolar, hydrophobic
residues). The second putative HR is adjacent to the trans-
membrane domain and is formed by amino acid residues 521 to
549 (HR2: VddMkinNdlEktnLheLtsrLydLrrrI). Further stud-
ies are in progress to confirm whether those motifs indeed are
required for the fusion function.
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